Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...
AC Immune SA has reported encouraging interim results from its phase 2 VacSYn clinical trial of ACI-7104.056, an ...
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
News Medical on MSN2d
New biomarker could help predict Parkinson’s disease progressionA team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...
Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...
The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...
Nottinghamshire Live on MSN6h
Nightmares could be a symptom of serious illnesses like Parkinson's or heart problemsNightmares can be caused by a range of conditions from Parkinson's to sleep apnoea - and they can even help diagnose your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback